Dow Jones

39,118.86

-0.12%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Avista Public Acquisition Corporation II (AHPA)
Avista Public Acquisition Corporation II (AHPA) Noticias

AHPA

Avista Public Acquisitio... (AHPA)

Avista Public Acquisition Corporation II

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AHPA

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
27/06/2023	17:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
26/06/2023	15:44	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
18/05/2023	15:39	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
11/05/2023	16:12	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
11/05/2023	05:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
05/05/2023	15:04	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
01/05/2023	08:05	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
01/05/2023	08:03	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
01/05/2023	08:02	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
31/03/2023	05:20	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
08/03/2023	13:16	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
13/02/2023	11:29	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
07/02/2023	05:10	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
05/01/2023	16:08	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
03/01/2023	16:00	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
30/11/2022	15:54	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
23/11/2022	08:02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
14/11/2022	15:39	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
14/11/2022	15:09	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
10/11/2022	16:12	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
01/11/2022	15:29	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
01/11/2022	09:32	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
24/10/2022	16:00	Business Wire	OmniAb Business Combination Approved by APAC Shareholders	NASDAQ:AHPA	Avista Public Acquisition Corporation II
03/10/2022	07:24	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
03/10/2022	07:00	PR Newswire (US)	Avista Public Acquisition Corp. II Announces Effectiveness of Registration Statement and Sets Date for Extraordinary General Meeting to Vote on Proposed Business Combination	NASDAQ:AHPA	Avista Public Acquisition Corporation II
27/09/2022	16:02	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
24/08/2022	16:00	Business Wire	Ligand Announces that Janssen has Received Approval from European Commission for TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma	NASDAQ:AHPA	Avista Public Acquisition Corporation II
08/08/2022	15:01	Business Wire	Ligand Reports Second Quarter 2022 Financial Results	NASDAQ:AHPA	Avista Public Acquisition Corporation II
16/05/2022	15:11	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:AHPA	Avista Public Acquisition Corporation II
04/05/2022	15:01	Business Wire	Ligand Reports First Quarter 2022 Financial Results	NASDAQ:AHPA	Avista Public Acquisition Corporation II